London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Triple procedure for the treatment of central anterior crystalline keratopathy

Poster Details

First Author: G.Eltaji Elfarouki IRELAND

Co Author(s):    A. Hamoud              

Abstract Details

Purpose:

To analyze the background evidence for triple simultaneous procedures for central anterior crystalline keratopathy and report on the course of a case that underwent that treatment

Setting:

Regional referral centre for ophthalmic surgery

Methods:

Crystalline keratopathy is a condition in which crystals are deposited in the corneal epithelium and/ or anterior stroma, and arises from a multitude of causes such as infection and corneal dystrophy (Gupta et al). Many persons who are pre-disposed to it are also prone to developing lenticular opacities. Surgical intervention for the different opacities may be carried out sequentially, but it has been reported that there is no significant increase in endothelial cell loss when corneal transplantation is combined with cataract surgery (Davis and Stark). We report on a case of recurrent intractable crystalline keratopathy, focusing on the use of triple simultaneous procedure surgery for treatment. Surgical management involved penetrating keratoplasty, cataract extraction and intra-ocular lens implantation in one surgical procedure. Patient history, presentation, investigations, treatment options, surgical procedure and clinical course are described and demonstrated.

Results:

Triple procedure rather than sequential surgery can be effective in suitably selected patients with crystalline keratopathy.

Conclusions:

-

Financial Disclosure:

NONE

Back to Poster listing